Response of Intractable Skin Ulcers in Recessive Dystrophic Epidermolysis Bullosa Patients to an Allogeneic Cultured Dermal Substitute

Authors

  • Ken Natsuga
  • Daisuke Sawamura
  • Maki Goto
  • Erina Homma
  • Yuka Goto-Ohguchi
  • Satoru Aoyagi
  • Masashi Akiyama
  • Yoshimitsu Kuroyanagi
  • Hiroshi Shimizu

DOI:

https://doi.org/10.2340/00015555-0776

Keywords:

epidermolysis bullosa, collagen VII, cultured dermal substitute, fibroblast, growth factor

Abstract

Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited skin disorder caused by mutations in the COL7A1 gene, which encodes collagen VII (COL7). Skin ulcers in RDEB patients are sometimes slow to heal. We describe here the therapeutic response of intractable skin ulcers in two patients with generalized RDEB to treatment with an allogeneic cultured dermal substitute (CDS). Skin ulcers in both patients epithelialized by 3–4 weeks after this treatment. Immunohistochemical studies demonstrated that the COL7 expression level remained reduced with respect to the control skin and that it did not differ significantly between graft-treated and untreated areas. Electron microscopy showed aberrant anchoring fibrils beneath the lamina densa of both specimens. In conclusion, CDS is a promising modality for treatment of intractable skin ulcers in patients with RDEB, even though it does not appear to increase COL7 expression.

Downloads

Download data is not yet available.

Downloads

Published

2010-01-04

How to Cite

Natsuga, K., Sawamura, D., Goto, M., Homma, E., Goto-Ohguchi, Y., Aoyagi, S., Akiyama, M., Kuroyanagi, Y., & Shimizu, H. (2010). Response of Intractable Skin Ulcers in Recessive Dystrophic Epidermolysis Bullosa Patients to an Allogeneic Cultured Dermal Substitute. Acta Dermato-Venereologica, 90(2), 165–169. https://doi.org/10.2340/00015555-0776

Issue

Section

Articles